Avant's Trivalent Vaccine Found Effective Against Enteric Diseases
Posted on: Monday, 10 December 2007, 06:00 CST
Avant Immunotherapeutics has reported that its experimental, single-dose, oral vaccine combining protection from enteric diseases has demonstrated positive immunogenicity and lack of immune interference in the preclinical studies.
The experimental, trivalent vaccine consists of the co-administration of two live-attenuated bacteria, the Peru-15pCTB vaccine candidate that forms the basis of Avant's investigational combination ETEC/cholera vaccine, and Avant's investigational typhoid fever vaccine, Ty800.
Avant has also said that the National Institutes of Health will be sponsoring a Phase I clinical trial of the Peru-15pCTB vaccine combining protection against ETEC and cholera in first quarter of 2008, and Avant's Ty800 is currently undergoing Phase II clinical testing.
Una Ryan,president and CEO of AVANT Immunotherapeutics, said: "If the results of these current clinical studies are successful, the preclinical data presented today pave the way for initial human clinical testing of a trivalent super-enteric vaccine."
Source: Datamonitor
Related Articles
- Emergent BioSolutions Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects
- ATCC Vero Cells Used To Manufacture Second Rotavirus Vaccine For Clinical Trials
- Sinovac Attended 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials
- Sinovac Announces Pandemic Influenza Vaccine Phase I Clinical Trial Preliminary Results
- Hemispherx Biopharma Advances Influenza Vaccine/Immunopotentiation Clinical Trials Designed to Increase Vaccine Dosage Supply and Increase Cross-Protection; Australian Clinical Protocol Complete
- Hemispherx Biopharma Announces Influenza Vaccine/Immunopotentiation Clinical Trials Designed to Increase Vaccine Dosage Supply and Increase Cross-Protection
- Federal Government, Vaccine Maker Finally Sign Deal to Make H5N1 Flu Vaccine
- Chinese Watchdog Approves Clinical Tests of Human Bird Flu Vaccine
- Delray Neurologist to Test Alzheimer's Vaccine
- Bird Flu Vaccine Passes U.S. Clinical Test
 |
 |
User Comments (0)
RSS Feeds